May 20, 2025 The Critical Path Institute Podcast: eCOA Conversations with Florence Mowlem, Karl McEvoy, and Brian Lillis Welcome to the latest Critical Path Institute Podcast episode—the first in the eCOA Conversations...
May 15, 2025 From Awareness to Action: How C-Path’s HD-RSC Is Transforming the Future of Huntington’s Disease May 15, marks Huntington’s Disease Awareness Day, a key moment during Huntington’s Awareness...
May 12, 2025 C-Path’s Translational Therapeutics Accelerator Awards $815,000 Grant for Drug Development Project in Advanced Prostate Cancer C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today an $815,000 ($1,250,000 AUD) grant to Brian...
May 8, 2025 Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration The year 2025 marks a historic milestone for C-Path as the organization celebrates...
May 6, 2025 C-Path Announces First Data Transfer from Takeda to Accelerate Alpha-1 Innovation TUCSON, Ariz., May 6, 2025 — Critical Path Institute’s® (C-Path) Critical Path for Alpha-1 (CPA-1) consortium is proud to...
September 12, 2025 2025 C-Path Global Impact Conference in Washington D.C. a Huge Success Building on the momentum of CGIC 2024, this year’s event brought together leaders and innovators from across the life sciences..
May 22, 2025 RDCA-DAP and NORD’s IAMRARE Platform to Platform Federation: Lessons Learned Patient data is a key asset in understanding the progression of rare diseases...
April 28, 2025 Lysosomal Storage Disease Data Sharing Webinar Series – Session #3: Retroactive Data Sharing The recent webinar from C-Path's Critical Path for Lysosomal Diseases (CPLD) team focused on the critical issue of...
April 25, 2025 Developing digital health technologies for frontotemporal degeneration Frontotemporal degeneration (FTD) is a rare neurodegenerative disease in which patients can present with cognitive, behavioral...
April 25, 2025 C-Path’s CPAD Database Drives Insights into Alzheimer’s Disease C-Path’s Critical Path for Alzheimer’s Disease (CPAD) Consortium is thrilled to share...